• 25 APR 16
    • 0

    Pharmatek’s Dir. of Manufacturing Business Operations to speak at upcoming topical focused presentation at BIOCOM on 4/27/16

    Topic: Skin-Applied Products: From Concept to Approvals in San Diego
    When: Wednesday, April 27, 2016 from 8:00 a.m. – 10:00 a.m.
    Where: BIOCOM- 10996 Torreyana Road ,Suite 200 San Diego, CA 92121

    Click Here to Learn More

    Speakers:
    Pieter Dorrestein, Director, Collaborative Mass Spectrometry Innovation Center (UCSD)
    New Learnings and Potential Treatments from Scrutiny of the Skin Microbiome

    Avadhesh Kushwaha, Pharmaceutical Formulation Scientist (Tioga Research)
    Opportunities for Innovation in Skin-Applied Formulations

    Kevin Rosenthal, Director, Manufacturing Business Development (Pharmatek Laboratories)
    Advancing a topical product into GMP production

    Dan Piacquadio, CEO (Therapeutics Inc)
    Challenges in the Clinical Development of Topical Products

    Moderator:
    John M Newsam, CEO (Tioga Research)

    Summary:
    Why are dermatology programs so much in favor with investors? Does it really take less time to advance a topical drug program through clinical trials and approvals? What has happened in formulation science that has created such opportunities for new topical products? Why would I favor a transdermal mode of administration over others? What is special about the skill sets required to advance a skin-applied product program?

    Hear answers to these questions. Learn how skin-applied product challenges are being addressed. Be prepared to quiz our expert panel on which classes of therapeutics lend themselves best to a skin-applied format, when a transdermal delivery route is preferred, and on how simple or complex a topical or transdermal development program can be.

    San Diego is developing as a major international center for skin-directed activities. We are fortunate to have a constellation of CROs and CMOs that can advance a topical drug program from concept all the way through Phase 2 and 3 clinical trials. The nature of the San Diego CRO community is such that it encourages inter-company cooperation. A client can then benefit from ‘best of breed’ strengths being brought to bear, while avoiding discontinuities that can arise elsewhere when technology transfer is needed. And these local strengths extend also to non-pharmaceutical beauty and hygiene products.

    Click Here to Learn More

    Leave a reply →

Leave a reply

Cancel reply